ArticlePharmaceuticals (Basel, Switzerland)2025

Design and Optimization of Spiro-Isatin-Thiazolidinone Hybrids with Promising Anticancer Activity.

Dmytro Khylyuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.